Prostacyclin and thromboxane levels during cardiac ischemia in dogs. 1985

M Prosdocimi, and F Tessari, and M Finesso, and A Gorio, and E Dejana, and L R Languino, and A Del Maschio, and G de Gaetano

UI MeSH Term Description Entries
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013929 Thromboxane B2 A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin). B2, Thromboxane
D013931 Thromboxanes Physiologically active compounds found in many organs of the body. They are formed in vivo from the prostaglandin endoperoxides and cause platelet aggregation, contraction of arteries, and other biological effects. Thromboxanes are important mediators of the actions of polyunsaturated fatty acids transformed by cyclooxygenase. Thromboxane
D015121 6-Ketoprostaglandin F1 alpha The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue. 6-Keto-PGF1 alpha,6-Oxo-PGF1 alpha,6-Oxoprostaglandin F1 alpha,6 Ketoprostaglandin F1 alpha,6 Keto PGF1 alpha,6 Oxo PGF1 alpha,6 Oxoprostaglandin F1 alpha,F1 alpha, 6-Ketoprostaglandin,F1 alpha, 6-Oxoprostaglandin,alpha, 6-Keto-PGF1,alpha, 6-Ketoprostaglandin F1,alpha, 6-Oxo-PGF1,alpha, 6-Oxoprostaglandin F1

Related Publications

M Prosdocimi, and F Tessari, and M Finesso, and A Gorio, and E Dejana, and L R Languino, and A Del Maschio, and G de Gaetano
January 1989, Progress in clinical and biological research,
M Prosdocimi, and F Tessari, and M Finesso, and A Gorio, and E Dejana, and L R Languino, and A Del Maschio, and G de Gaetano
July 1983, Ophthalmology,
M Prosdocimi, and F Tessari, and M Finesso, and A Gorio, and E Dejana, and L R Languino, and A Del Maschio, and G de Gaetano
April 1986, Neurology,
M Prosdocimi, and F Tessari, and M Finesso, and A Gorio, and E Dejana, and L R Languino, and A Del Maschio, and G de Gaetano
January 1987, The Journal of thoracic and cardiovascular surgery,
M Prosdocimi, and F Tessari, and M Finesso, and A Gorio, and E Dejana, and L R Languino, and A Del Maschio, and G de Gaetano
March 1995, The Annals of thoracic surgery,
M Prosdocimi, and F Tessari, and M Finesso, and A Gorio, and E Dejana, and L R Languino, and A Del Maschio, and G de Gaetano
April 1981, The Journal of pharmacology and experimental therapeutics,
M Prosdocimi, and F Tessari, and M Finesso, and A Gorio, and E Dejana, and L R Languino, and A Del Maschio, and G de Gaetano
March 1987, The Journal of surgical research,
M Prosdocimi, and F Tessari, and M Finesso, and A Gorio, and E Dejana, and L R Languino, and A Del Maschio, and G de Gaetano
March 1988, Kardiologiia,
M Prosdocimi, and F Tessari, and M Finesso, and A Gorio, and E Dejana, and L R Languino, and A Del Maschio, and G de Gaetano
September 1984, British journal of obstetrics and gynaecology,
M Prosdocimi, and F Tessari, and M Finesso, and A Gorio, and E Dejana, and L R Languino, and A Del Maschio, and G de Gaetano
June 1985, British journal of obstetrics and gynaecology,
Copied contents to your clipboard!